Cutaneous effects of sirolimus in renal transplant recipients
Warino, L.; Libecco, J.
Journal of Drugs in Dermatology Jdd 5(3): 273-274
2006
ISSN/ISBN: 1545-9616 PMID: 16573262 Document Number: 8644
Cancer is a major cause of death in immunosuppressed transplant patients. Therefore, sirolimus is frequently used in these patients for its immunosuppressive and antineoplastic properties. However, a variety of cutaneous side effects have resulted from sirolimus therapy. Consequently, dermatologists must be aware of such adverse events and understand the risks and benefits of discontinuing therapy.
Document emailed within 1 workday
Related Documents
Namjud, N.; Chariyavilaskul, P.; Townamchai, N.; Wittayalertpanya, S. 2015: A reduction of asymmetric dimethylarginine in renal transplant recipients receiving sirolimus-based regimen Journal of the Medical Association of Thailand 98(Suppl 1): S9-13Johnson, E.M.; Zimmerman, J.; Duderstadt, K.; Chambers, J.; Sorenson, A.L.; Granger, D.K.; Almond, P.S.; Fryer, J.p.; Leventhal, J.R.; Scarola, J.; Matas, A.J.; Canafax, D.M. 1996: A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients Transplantation Proceedings 28(2): 987
Wackym, P.A.; Gray, G.F.; Richie, R.E.; Gregg, C.R. 1985: Cutaneous chromomycosis in renal transplant recipients. Successful management in two cases Archives of Internal Medicine 145(6): 1036-1037
Homan van der Heide, J.J.; Bilo, H.J.; Donker, A.J.; Wilmink, J.M.; Sluiter, W.J.; Tegzess, A.M. 1992: The effects of dietary supplementation with fish oil on renal function and the course of early postoperative rejection episodes in cyclosporine-treated renal transplant recipients Transplantation 54(2): 257-263
Laine, J.; Holmberg, C. 1996: Tubular effects of cyclosporine in pediatric renal transplant recipients Transplantation Proceedings 28(4): 2104-2106
Bouzas, L.; Carlos, J. Tutor 2011: Determination of Blood Everolimus Concentrations in Kidney and Liver Transplant Recipients Using the Sirolimus Antibody Conjugated Magnetic Immunoassay (ACMIA) Clinical Laboratory 57(5-6): 403-406
Shoskes, D.A.; Hodge, E.E.; Goormastic, M.; Goldfarb, D.A.; Novick, A.C. 1995: HLA matching determines susceptibility to harmful effects of delayed graft function in renal transplant recipients Transplantation Proceedings 27(1): 1068-1069
Potena, L.; Grigioni, F.; Magnani, G.; Sorbello, S.; Sassi, S.; Marinucci, L.; Conti, R.; Carinci, V.; Leone, O.; Arpesella, G.; Coccheri, S.; Magelli, C.; Branzi, A. 2000: Increasing plasma homocysteine during follow-up in heart transplant recipients: effects of folate and renal function Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 1(5): 344-348
Driscoll, D.F.; Pinson, C.W.; Jenkins, R.L.; Bistrian, B.R. 1989: Potential protective effects of furosemide against early cyclosporine-induced renal injury in hepatic transplant recipients Transplantation Proceedings 21(3): 3549-3550
Harmon, W.E.; Stablein, D.; Alexander, S.R.; Tejani, A. 1991: Graft thrombosis in pediatric renal transplant recipients. A report of the North American Pediatric Renal Transplant Cooperative Study Transplantation 51(2): 406-412
Kimball, P.M.; King, A. 2011: A novel post-transplant alloantibody surveillance and intervention strategy that improves graft outcomes in sensitized renal transplant recipients Clinical Transplants 2011: 369-372
Mirza, S.; Mahmud, S.N.; Abideen, Z.U.; Aziz, T.; Akhter, S.; Baloch, B.K. 2019: Overcoming the Immunological Barrier in Highly HLA Sensitized Renal Transplant Recipients - a Desensitization Experience from a Transplant Center in Pakistan JPMA. Journal of the Pakistan Medical Association 69(4): 584-587
Euvrard, S.; Kanitakis, J.; Claudy, A. 2002: Cutaneous tumors in organ transplant recipients Presse Medicale 31(40): 1895-1903
Aufy, S.M.; Mahgoub, A.M.A.; Saadi, M.G.E.-D.; Adel Elmallawany, M. 2009: Serological detection of Toxoplasma gondii in chronic renal failure patients and renal transplant recipients Journal of the Egyptian Society of Parasitology 39(3): 943-950
Kahan, B.D.; Julian, B.A.; Pescovitz, M.D.; Vanrenterghem, Y.; Neylan, J. 1999: Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group Transplantation 68(10): 1526-1532
Ternesten-Bratel, A.; Kjellström, C.; Wennberg, A.-M.; Ricksten, A. 2003: Cutaneous squamoproliferative lesions in kidney transplant recipients: an investigation of specific Epstein-Barr virus expression Acta Dermato-Venereologica 83(1): 14-17
Hussain, Z.; Hashmi, A.; Ather, H.; Mohsin, R.; Hussain, M.; Naqvi, A.; Rizvi, A. 1995: Erythrocytosis in renal transplant recipients Transplantation Proceedings 27(5): 2736
El-Sharabasy, M.M.; el-Naggar, M.N. 1991: Prostaglandin E2 in renal transplant recipients Acta Medica Hungarica 48(3-4): 225-229
Solá, R.; Rodríguez, S.; Guirado, L.; Löpez-Navidad, A.; Caballero, F.; Diaz, M.; Baro, E.; Paredes, D. 2000: Renal transplant for recipients over 60 years old Transplantation 69(11): 2460-2461
Sakellariou, G.; Memmos, D.; Alexopoulos, E.; Tsobanelis, T.; Sinakos, Z.; Papadimitriou, M. 1986: Cancer in renal transplant recipients Cancer Detection and Prevention 9(3-4): 389-393